|
Fusion Gene Summary | |
Fusion Gene ORF analysis | |
Fusion Genomic Features | |
Fusion Protein Features | |
Fusion Gene Sequence | |
Fusion Gene PPI analysis | |
Related Drugs | |
Related Diseases |
Fusion gene:PELP1-CHRNE (FusionGDB2 ID:64264) |
Fusion Gene Summary for PELP1-CHRNE |
Fusion gene summary |
Fusion gene information | Fusion gene name: PELP1-CHRNE | Fusion gene ID: 64264 | Hgene | Tgene | Gene symbol | PELP1 | CHRNE | Gene ID | 27043 | 1145 |
Gene name | proline, glutamate and leucine rich protein 1 | cholinergic receptor nicotinic epsilon subunit | |
Synonyms | MNAR|P160 | ACHRE|CMS1D|CMS1E|CMS2A|CMS4A|CMS4B|CMS4C|FCCMS|SCCMS | |
Cytomap | 17p13.2 | 17p13.2 | |
Type of gene | protein-coding | protein-coding | |
Description | proline-, glutamic acid- and leucine-rich protein 1modulator of non-genomic activity of estrogen receptorproline and glutamic acid rich nuclear proteintranscription factor HMX3 | acetylcholine receptor subunit epsilonAchR epsilon subunitacetylcholine receptor, nicotinic, epsilon (muscle)cholinergic receptor, nicotinic epsiloncholinergic receptor, nicotinic, epsilon (muscle)cholinergic receptor, nicotinic, epsilon polypeptide | |
Modification date | 20200329 | 20200313 | |
UniProtAcc | . | . | |
Ensembl transtripts involved in fusion gene | ENST00000269230, ENST00000301396, ENST00000436683, ENST00000572293, ENST00000574876, ENST00000570823, | ENST00000575637, ENST00000293780, | |
Fusion gene scores | * DoF score | 4 X 5 X 4=80 | 2 X 2 X 2=8 |
# samples | 6 | 3 | |
** MAII score | log2(6/80*10)=-0.415037499278844 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(3/8*10)=1.90689059560852 | |
Context | PubMed: PELP1 [Title/Abstract] AND CHRNE [Title/Abstract] AND fusion [Title/Abstract] | ||
Most frequent breakpoint | PELP1(4579652)-CHRNE(4806058), # samples:2 | ||
Anticipated loss of major functional domain due to fusion event. | PELP1-CHRNE seems lost the major protein functional domain in Hgene partner, which is a epigenetic factor due to the frame-shifted ORF. PELP1-CHRNE seems lost the major protein functional domain in Tgene partner, which is a IUPHAR drug target due to the frame-shifted ORF. |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
Partner | Gene | GO ID | GO term | PubMed ID |
Hgene | PELP1 | GO:0045944 | positive regulation of transcription by RNA polymerase II | 17505058 |
Hgene | PELP1 | GO:0071391 | cellular response to estrogen stimulus | 17505058 |
Fusion gene breakpoints across PELP1 (5'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Fusion gene breakpoints across CHRNE (3'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Fusion gene information from two resources (ChiTars 5.0 and ChimerDB 4.0) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
ChimerDB4 | LUSC | TCGA-18-4083-01A | PELP1 | chr17 | 4607158 | - | CHRNE | chr17 | 4806058 | - |
ChimerDB4 | LUSC | TCGA-60-2719-01A | PELP1 | chr17 | 4579652 | - | CHRNE | chr17 | 4806058 | - |
ChimerDB4 | LUSC | TCGA-60-2719 | PELP1 | chr17 | 4579652 | - | CHRNE | chr17 | 4806058 | - |
Top |
Fusion Gene ORF analysis for PELP1-CHRNE |
Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
5CDS-intron | ENST00000269230 | ENST00000575637 | PELP1 | chr17 | 4607158 | - | CHRNE | chr17 | 4806058 | - |
5CDS-intron | ENST00000269230 | ENST00000575637 | PELP1 | chr17 | 4579652 | - | CHRNE | chr17 | 4806058 | - |
5CDS-intron | ENST00000301396 | ENST00000575637 | PELP1 | chr17 | 4607158 | - | CHRNE | chr17 | 4806058 | - |
5CDS-intron | ENST00000301396 | ENST00000575637 | PELP1 | chr17 | 4579652 | - | CHRNE | chr17 | 4806058 | - |
5CDS-intron | ENST00000436683 | ENST00000575637 | PELP1 | chr17 | 4579652 | - | CHRNE | chr17 | 4806058 | - |
5CDS-intron | ENST00000572293 | ENST00000575637 | PELP1 | chr17 | 4607158 | - | CHRNE | chr17 | 4806058 | - |
5CDS-intron | ENST00000572293 | ENST00000575637 | PELP1 | chr17 | 4579652 | - | CHRNE | chr17 | 4806058 | - |
5CDS-intron | ENST00000574876 | ENST00000575637 | PELP1 | chr17 | 4607158 | - | CHRNE | chr17 | 4806058 | - |
5CDS-intron | ENST00000574876 | ENST00000575637 | PELP1 | chr17 | 4579652 | - | CHRNE | chr17 | 4806058 | - |
5UTR-3CDS | ENST00000436683 | ENST00000293780 | PELP1 | chr17 | 4607158 | - | CHRNE | chr17 | 4806058 | - |
5UTR-3CDS | ENST00000570823 | ENST00000293780 | PELP1 | chr17 | 4607158 | - | CHRNE | chr17 | 4806058 | - |
5UTR-intron | ENST00000436683 | ENST00000575637 | PELP1 | chr17 | 4607158 | - | CHRNE | chr17 | 4806058 | - |
5UTR-intron | ENST00000570823 | ENST00000575637 | PELP1 | chr17 | 4607158 | - | CHRNE | chr17 | 4806058 | - |
Frame-shift | ENST00000269230 | ENST00000293780 | PELP1 | chr17 | 4607158 | - | CHRNE | chr17 | 4806058 | - |
Frame-shift | ENST00000301396 | ENST00000293780 | PELP1 | chr17 | 4607158 | - | CHRNE | chr17 | 4806058 | - |
Frame-shift | ENST00000436683 | ENST00000293780 | PELP1 | chr17 | 4579652 | - | CHRNE | chr17 | 4806058 | - |
Frame-shift | ENST00000572293 | ENST00000293780 | PELP1 | chr17 | 4607158 | - | CHRNE | chr17 | 4806058 | - |
Frame-shift | ENST00000574876 | ENST00000293780 | PELP1 | chr17 | 4607158 | - | CHRNE | chr17 | 4806058 | - |
In-frame | ENST00000269230 | ENST00000293780 | PELP1 | chr17 | 4579652 | - | CHRNE | chr17 | 4806058 | - |
In-frame | ENST00000301396 | ENST00000293780 | PELP1 | chr17 | 4579652 | - | CHRNE | chr17 | 4806058 | - |
In-frame | ENST00000572293 | ENST00000293780 | PELP1 | chr17 | 4579652 | - | CHRNE | chr17 | 4806058 | - |
In-frame | ENST00000574876 | ENST00000293780 | PELP1 | chr17 | 4579652 | - | CHRNE | chr17 | 4806058 | - |
intron-3CDS | ENST00000570823 | ENST00000293780 | PELP1 | chr17 | 4579652 | - | CHRNE | chr17 | 4806058 | - |
intron-intron | ENST00000570823 | ENST00000575637 | PELP1 | chr17 | 4579652 | - | CHRNE | chr17 | 4806058 | - |
ORFfinder result based on the fusion transcript sequence of in-frame fusion genes. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
ENST00000574876 | PELP1 | chr17 | 4579652 | - | ENST00000293780 | CHRNE | chr17 | 4806058 | - | 3269 | 871 | 18 | 2306 | 762 |
ENST00000572293 | PELP1 | chr17 | 4579652 | - | ENST00000293780 | CHRNE | chr17 | 4806058 | - | 3465 | 1067 | 49 | 2502 | 817 |
ENST00000269230 | PELP1 | chr17 | 4579652 | - | ENST00000293780 | CHRNE | chr17 | 4806058 | - | 3477 | 1079 | 61 | 2514 | 817 |
ENST00000301396 | PELP1 | chr17 | 4579652 | - | ENST00000293780 | CHRNE | chr17 | 4806058 | - | 3477 | 1079 | 61 | 2514 | 817 |
DeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
ENST00000574876 | ENST00000293780 | PELP1 | chr17 | 4579652 | - | CHRNE | chr17 | 4806058 | - | 0.021441292 | 0.97855866 |
ENST00000572293 | ENST00000293780 | PELP1 | chr17 | 4579652 | - | CHRNE | chr17 | 4806058 | - | 0.020917295 | 0.97908264 |
ENST00000269230 | ENST00000293780 | PELP1 | chr17 | 4579652 | - | CHRNE | chr17 | 4806058 | - | 0.021335451 | 0.9786646 |
ENST00000301396 | ENST00000293780 | PELP1 | chr17 | 4579652 | - | CHRNE | chr17 | 4806058 | - | 0.021335451 | 0.9786646 |
Top |
Fusion Genomic Features for PELP1-CHRNE |
FusionAI prediction of the potential fusion gene breakpoint based on the pre-mature RNA sequence context (+/- 5kb of individual partner genes, total 20kb length sequence). FusionAI is a fusion gene breakpoint classifier based on convolutional neural network by comparing the fusion positive and negative sequence context of ~ 20K fusion gene data. From here, we can have the relative potentency of the 20K genomic sequence how individual sequnce will be likely used as the gene fusion breakpoints. |
Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | 1-p | p (fusion gene breakpoint) |
Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions. We integrated a total of 44 different types of human genomic feature loci information across five big categories including virus integration sites, repeats, structural variants, chromatin states, and gene expression regulation. More details are in help page. |
Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions that are ovelapped with the top 1% feature importance score regions. More details are in help page. |
Top |
Fusion Protein Features for PELP1-CHRNE |
Four levels of functional features of fusion genes Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr17:4579652/chr17:4806058) - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. - How to search 1. Put your fusion gene symbol. 2. Press the tab key until there will be shown the breakpoint information filled. 4. Go down and press 'Search' tab twice. 4. Go down to have the hyperlink of the search result. 5. Click the hyperlink. 6. See the FGviewer result for your fusion gene. |
Main function of each fusion partner protein. (from UniProt) |
Hgene | Tgene |
. | . |
FUNCTION: Transcriptional activator which is required for calcium-dependent dendritic growth and branching in cortical neurons. Recruits CREB-binding protein (CREBBP) to nuclear bodies. Component of the CREST-BRG1 complex, a multiprotein complex that regulates promoter activation by orchestrating a calcium-dependent release of a repressor complex and a recruitment of an activator complex. In resting neurons, transcription of the c-FOS promoter is inhibited by BRG1-dependent recruitment of a phospho-RB1-HDAC1 repressor complex. Upon calcium influx, RB1 is dephosphorylated by calcineurin, which leads to release of the repressor complex. At the same time, there is increased recruitment of CREBBP to the promoter by a CREST-dependent mechanism, which leads to transcriptional activation. The CREST-BRG1 complex also binds to the NR2B promoter, and activity-dependent induction of NR2B expression involves a release of HDAC1 and recruitment of CREBBP (By similarity). {ECO:0000250}. | FUNCTION: Transcriptional activator which is required for calcium-dependent dendritic growth and branching in cortical neurons. Recruits CREB-binding protein (CREBBP) to nuclear bodies. Component of the CREST-BRG1 complex, a multiprotein complex that regulates promoter activation by orchestrating a calcium-dependent release of a repressor complex and a recruitment of an activator complex. In resting neurons, transcription of the c-FOS promoter is inhibited by BRG1-dependent recruitment of a phospho-RB1-HDAC1 repressor complex. Upon calcium influx, RB1 is dephosphorylated by calcineurin, which leads to release of the repressor complex. At the same time, there is increased recruitment of CREBBP to the promoter by a CREST-dependent mechanism, which leads to transcriptional activation. The CREST-BRG1 complex also binds to the NR2B promoter, and activity-dependent induction of NR2B expression involves a release of HDAC1 and recruitment of CREBBP (By similarity). {ECO:0000250}. |
Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | PELP1 | chr17:4579652 | chr17:4806058 | ENST00000574876 | - | 7 | 17 | 111_115 | 284 | 1131.0 | Motif | Note=LXXLL motif 3 |
Hgene | PELP1 | chr17:4579652 | chr17:4806058 | ENST00000574876 | - | 7 | 17 | 155_159 | 284 | 1131.0 | Motif | Note=LXXLL motif 4 |
Hgene | PELP1 | chr17:4579652 | chr17:4806058 | ENST00000574876 | - | 7 | 17 | 177_181 | 284 | 1131.0 | Motif | Note=LXXLL motif 5 |
Hgene | PELP1 | chr17:4579652 | chr17:4806058 | ENST00000574876 | - | 7 | 17 | 264_268 | 284 | 1131.0 | Motif | Note=LXXLL motif 6 |
Hgene | PELP1 | chr17:4579652 | chr17:4806058 | ENST00000574876 | - | 7 | 17 | 271_275 | 284 | 1131.0 | Motif | Note=LXXLL motif 7 |
Hgene | PELP1 | chr17:4579652 | chr17:4806058 | ENST00000574876 | - | 7 | 17 | 33_37 | 284 | 1131.0 | Motif | Note=LXXLL motif 1 |
Hgene | PELP1 | chr17:4579652 | chr17:4806058 | ENST00000574876 | - | 7 | 17 | 69_73 | 284 | 1131.0 | Motif | Note=LXXLL motif 2 |
Tgene | CHRNE | chr17:4579652 | chr17:4806058 | ENST00000293780 | 0 | 12 | 21_239 | 15 | 494.0 | Topological domain | Extracellular | |
Tgene | CHRNE | chr17:4579652 | chr17:4806058 | ENST00000293780 | 0 | 12 | 265_272 | 15 | 494.0 | Topological domain | Cytoplasmic | |
Tgene | CHRNE | chr17:4579652 | chr17:4806058 | ENST00000293780 | 0 | 12 | 292_306 | 15 | 494.0 | Topological domain | Extracellular | |
Tgene | CHRNE | chr17:4579652 | chr17:4806058 | ENST00000293780 | 0 | 12 | 329_456 | 15 | 494.0 | Topological domain | Cytoplasmic | |
Tgene | CHRNE | chr17:4579652 | chr17:4806058 | ENST00000293780 | 0 | 12 | 481_493 | 15 | 494.0 | Topological domain | Extracellular | |
Tgene | CHRNE | chr17:4579652 | chr17:4806058 | ENST00000293780 | 0 | 12 | 240_264 | 15 | 494.0 | Transmembrane | Helical | |
Tgene | CHRNE | chr17:4579652 | chr17:4806058 | ENST00000293780 | 0 | 12 | 273_291 | 15 | 494.0 | Transmembrane | Helical | |
Tgene | CHRNE | chr17:4579652 | chr17:4806058 | ENST00000293780 | 0 | 12 | 307_328 | 15 | 494.0 | Transmembrane | Helical | |
Tgene | CHRNE | chr17:4579652 | chr17:4806058 | ENST00000293780 | 0 | 12 | 457_480 | 15 | 494.0 | Transmembrane | Helical |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | PELP1 | chr17:4579652 | chr17:4806058 | ENST00000574876 | - | 7 | 17 | 633_872 | 284 | 1131.0 | Compositional bias | Note=Pro-rich |
Hgene | PELP1 | chr17:4579652 | chr17:4806058 | ENST00000574876 | - | 7 | 17 | 888_1101 | 284 | 1131.0 | Compositional bias | Note=Glu-rich |
Hgene | PELP1 | chr17:4579652 | chr17:4806058 | ENST00000574876 | - | 7 | 17 | 977_1083 | 284 | 1131.0 | Compositional bias | Note=Pro-rich |
Hgene | PELP1 | chr17:4579652 | chr17:4806058 | ENST00000574876 | - | 7 | 17 | 364_368 | 284 | 1131.0 | Motif | Note=LXXLL motif 8 |
Hgene | PELP1 | chr17:4579652 | chr17:4806058 | ENST00000574876 | - | 7 | 17 | 459_463 | 284 | 1131.0 | Motif | Note=LXXLL motif 9 |
Hgene | PELP1 | chr17:4579652 | chr17:4806058 | ENST00000574876 | - | 7 | 17 | 579_583 | 284 | 1131.0 | Motif | Note=LXXLL motif 10 |
Hgene | PELP1 | chr17:4579652 | chr17:4806058 | ENST00000574876 | - | 7 | 17 | 584_588 | 284 | 1131.0 | Motif | Note=LXXLL motif 11 |
Top |
Fusion Gene Sequence for PELP1-CHRNE |
For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. To have fusion amino acid sequence, we ran ORFfinder and chose the longest ORF among the all predicted ones. |
>64264_64264_1_PELP1-CHRNE_PELP1_chr17_4579652_ENST00000269230_CHRNE_chr17_4806058_ENST00000293780_length(transcript)=3477nt_BP=1079nt ACAGGCAGCCTCATCCGCCATCACTCCGGGAACCGAGCACCCCGCTGCCTCGGCGCCCAGGCTGCTCTCTCCGCGCATGCTCCTTCCCAG CTTGAGCCCGCGAGTCCAGCCTGCCTTCACTCAGTGCGCAAGACCGCAGCCCCCTCCCCACGCCCCCTCCCCAGTAGGCGGCCGTCGCGG TGTGTTTGCGTCATCGCGCCACGCCACCACTGGAACCCGGGGGAAGATGGCGGCAGCCGTTCTGAGTGGGCCCTCTGCGGGCTCCGCGGC TGGGGTTCCTGGCGGGACCGGGGGTCTCTCGGCAGTGAGCTCGGGCCCGCGGCTCCGCCTGCTGCTGCTGGAGAGTGTTTCTGGTTTGCT GCAACCTCGAACGGGGTCTGCCGTTGCTCCGGTGCATCCCCCAAACCGCTCGGCCCCACATTTGCCCGGGCTCATGTGCCTATTGCGGCT GCATGGGTCGGTGGGCGGGGCCCAGAACCTTTCAGCTCTTGGGGCATTGGTGAGTCTCAGTAATGCACGTCTCAGTTCCATCAAAACTCG GTTTGAGGGCCTGTGTCTGCTGTCCCTGCTGGTAGGGGAGAGCCCCACAGAGCTATTCCAGCAGCACTGTGTGTCTTGGCTTCGGAGCAT TCAGCAGGTGTTACAGACCCAGGACCCGCCTGCCACAATGGAGCTGGCCGTGGCTGTCCTGAGGGACCTCCTCCGATATGCAGCCCAGCT GCCTGCACTGTTCCGGGACATCTCCATGAACCACCTCCCTGGCCTTCTCACCTCCCTGCTGGGCCTCAGGCCAGAGTGTGAGCAGTCAGC ATTGGAAGGAATGAAGGCTTGTATGACCTATTTCCCTCGGGCTTGTGGTTCTCTCAAAGGCAAGCTGGCCTCATTTTTTCTGTCTAGGGT GGATGCCTTGAGCCCTCAGCTCCAACAGTTGGCCTGTGAGTGTTATTCCCGGCTGCCCTCTTTAGGGGCTGGCTTTTCCCAAGGCCTGAA GCACACCGAGAGCTGGGAGCAGGAGCTACACAGTCTGCTGGCCTCACTGCACACCCTGCTGGGGGCCCTGTACGAGGGAGCAGAGACTGG CAGGGGTGTGGGGAAGAACGAGGAACTGCGTCTTTATCACCATCTCTTCAACAACTATGACCCAGGAAGCCGGCCAGTGCGGGAGCCTGA GGATACTGTCACCATCAGCCTCAAGGTCACCCTGACGAATCTCATCTCACTGAATGAAAAAGAGGAGACTCTCACCACTAGCGTCTGGAT TGGAATCGATTGGCAGGATTACCGACTCAACTACAGCAAGGACGACTTTGGGGGTATAGAAACCCTGCGAGTCCCTTCAGAACTCGTGTG GCTGCCAGAGATTGTGCTGGAAAACAATATTGATGGCCAGTTCGGAGTGGCCTACGACGCCAACGTGCTCGTCTACGAGGGCGGCTCCGT GACGTGGCTGCCTCCGGCCATCTACCGCAGCGTCTGCGCAGTGGAGGTCACCTACTTCCCCTTCGATTGGCAGAACTGTTCGCTTATTTT CCGCTCTCAGACGTACAATGCCGAAGAGGTGGAGTTCACTTTTGCCGTAGACAACGACGGCAAGACCATCAACAAGATCGACATCGACAC AGAGGCCTATACTGAGAACGGCGAGTGGGCCATCGACTTCTGCCCGGGGGTGATCCGCCGCCACCACGGTGGCGCCACCGACGGCCCAGG GGAGACTGACGTCATCTACTCGCTCATCATCCGCCGGAAGCCGCTCTTCTACGTCATTAACATCATCGTGCCCTGTGTGCTCATCTCGGG CCTGGTGCTGCTCGCCTACTTCCTGCCGGCGCAGGCCGGCGGCCAGAAATGCACGGTCTCCATCAACGTCCTGCTCGCCCAGACCGTCTT CTTGTTCCTCATTGCCCAGAAAATCCCAGAGACTTCTCTGAGCGTGCCGCTCCTGGGCAGGTTCCTTATTTTCGTCATGGTGGTCGCCAC GCTCATTGTCATGAATTGCGTCATCGTGCTCAACGTGTCCCAGCGGACGCCCACCACCCACGCCATGTCCCCGCGGCTGCGCCACGTTCT CCTGGAGCTGCTGCCGCGCCTCCTGGGCTCCCCGCCGCCGCCCGAGGCCCCCCGGGCCGCCTCGCCCCCAAGGCGGGCGTCGTCGGTGGG CTTATTGCTCCGCGCGGAGGAGCTGATACTGAAAAAGCCACGGAGCGAGCTCGTGTTTGAGGGGCAGAGGCACCGGCAGGGGACCTGGAC GGCTGCCTTCTGCCAGAGCCTGGGCGCCGCCGCCCCCGAGGTCCGCTGCTGTGTGGATGCCGTGAACTTCGTGGCCGAGAGCACGAGAGA TCAGGAGGCCACCGGCGAGGAAGTGTCCGACTGGGTGCGCATGGGGAATGCCCTTGACAACATCTGCTTCTGGGCCGCTCTGGTGCTCTT CAGCGTGGGCTCCAGCCTCATCTTCCTCGGGGCCTACTTCAACCGAGTGCCTGATCTCCCCTACGCGCCGTGTATCCAGCCTTAGCTCGC ACCGACTTCAATTTCCCACCCATCTCCAGTAGGAAATTGATTTTGAAAAAGTAGGCTGCCGCCACCACGGCATTATGATCCCTTCCCCCT GCTGATCAATCTGCAGTTTGTGAACTTCACAAGAATGGTGTGTGCCCGTTCCCTGGCGTGTGTAGGCCTGGCCGCAGTCCAGGGGTCAGC AGGAGGAAAGGGTTCACATAGGCTCTCAGGTGCCAGTCTTCCAGAAAGCAAGGACTGCCCTTCATTCAGCCTTGCTGACCTCCCAGCCTT TCTAAGGCTCAGCCCCACGGGACTCTGGTGGCTGCCAGCTTGTGAGCTATCTATCTATATTCATTTCATAGCCAAACAGGAGACCCCTTT GCAGGACTTGCACACAGGGAGGCTGTAGCCAGGAAACCCTCTTCTTCCCTGGTCTGGCTCTGCTGGAGCGGGTGGGAACCAAACACCTTC AGTGCTGGTGGCCCTCAGGCCCACAGGTTTAAGGCTGAGGCTGCCCTGACCCTTCCACAGTCATTTCTTCTAGGTTTTCTTGGCCCAGCA CTGCCCATCCCACCCCATGAGGCTCACTCATTGCAGATCCCAGCCCACCCTGCCCCTTTCTTCCCCACCCTGGAGGCTCTCTCTGCCTAG TCTACAGTACTGACAGAAAGCAAGGACATGCGGCCTGCATGGTGGGAGCTGGTTGAATTGTCTTTATTAACAAACAGGATATCCAAGGCC ACTACATTGAGGAGGGGTGGGGGGGGAGGGAGAAGGGTTACTTGCTGCTCACACTATATACAGATGCAAGCAAGGGGCGTGGAGAGTGAG GGCTCCCTGCTCCCTCCCTCCACCGGGGAAGGGCATGGGCTAGAAGAGGAGAGGGGGGTCGGGAATGGGGGGAATGTTTTGGCTGGCGGG >64264_64264_1_PELP1-CHRNE_PELP1_chr17_4579652_ENST00000269230_CHRNE_chr17_4806058_ENST00000293780_length(amino acids)=817AA_BP=339 MLSPRMLLPSLSPRVQPAFTQCARPQPPPHAPSPVGGRRGVFASSRHATTGTRGKMAAAVLSGPSAGSAAGVPGGTGGLSAVSSGPRLRL LLLESVSGLLQPRTGSAVAPVHPPNRSAPHLPGLMCLLRLHGSVGGAQNLSALGALVSLSNARLSSIKTRFEGLCLLSLLVGESPTELFQ QHCVSWLRSIQQVLQTQDPPATMELAVAVLRDLLRYAAQLPALFRDISMNHLPGLLTSLLGLRPECEQSALEGMKACMTYFPRACGSLKG KLASFFLSRVDALSPQLQQLACECYSRLPSLGAGFSQGLKHTESWEQELHSLLASLHTLLGALYEGAETGRGVGKNEELRLYHHLFNNYD PGSRPVREPEDTVTISLKVTLTNLISLNEKEETLTTSVWIGIDWQDYRLNYSKDDFGGIETLRVPSELVWLPEIVLENNIDGQFGVAYDA NVLVYEGGSVTWLPPAIYRSVCAVEVTYFPFDWQNCSLIFRSQTYNAEEVEFTFAVDNDGKTINKIDIDTEAYTENGEWAIDFCPGVIRR HHGGATDGPGETDVIYSLIIRRKPLFYVINIIVPCVLISGLVLLAYFLPAQAGGQKCTVSINVLLAQTVFLFLIAQKIPETSLSVPLLGR FLIFVMVVATLIVMNCVIVLNVSQRTPTTHAMSPRLRHVLLELLPRLLGSPPPPEAPRAASPPRRASSVGLLLRAEELILKKPRSELVFE GQRHRQGTWTAAFCQSLGAAAPEVRCCVDAVNFVAESTRDQEATGEEVSDWVRMGNALDNICFWAALVLFSVGSSLIFLGAYFNRVPDLP -------------------------------------------------------------- >64264_64264_2_PELP1-CHRNE_PELP1_chr17_4579652_ENST00000301396_CHRNE_chr17_4806058_ENST00000293780_length(transcript)=3477nt_BP=1079nt ACAGGCAGCCTCATCCGCCATCACTCCGGGAACCGAGCACCCCGCTGCCTCGGCGCCCAGGCTGCTCTCTCCGCGCATGCTCCTTCCCAG CTTGAGCCCGCGAGTCCAGCCTGCCTTCACTCAGTGCGCAAGACCGCAGCCCCCTCCCCACGCCCCCTCCCCAGTAGGCGGCCGTCGCGG TGTGTTTGCGTCATCGCGCCACGCCACCACTGGAACCCGGGGGAAGATGGCGGCAGCCGTTCTGAGTGGGCCCTCTGCGGGCTCCGCGGC TGGGGTTCCTGGCGGGACCGGGGGTCTCTCGGCAGTGAGCTCGGGCCCGCGGCTCCGCCTGCTGCTGCTGGAGAGTGTTTCTGGTTTGCT GCAACCTCGAACGGGGTCTGCCGTTGCTCCGGTGCATCCCCCAAACCGCTCGGCCCCACATTTGCCCGGGCTCATGTGCCTATTGCGGCT GCATGGGTCGGTGGGCGGGGCCCAGAACCTTTCAGCTCTTGGGGCATTGGTGAGTCTCAGTAATGCACGTCTCAGTTCCATCAAAACTCG GTTTGAGGGCCTGTGTCTGCTGTCCCTGCTGGTAGGGGAGAGCCCCACAGAGCTATTCCAGCAGCACTGTGTGTCTTGGCTTCGGAGCAT TCAGCAGGTGTTACAGACCCAGGACCCGCCTGCCACAATGGAGCTGGCCGTGGCTGTCCTGAGGGACCTCCTCCGATATGCAGCCCAGCT GCCTGCACTGTTCCGGGACATCTCCATGAACCACCTCCCTGGCCTTCTCACCTCCCTGCTGGGCCTCAGGCCAGAGTGTGAGCAGTCAGC ATTGGAAGGAATGAAGGCTTGTATGACCTATTTCCCTCGGGCTTGTGGTTCTCTCAAAGGCAAGCTGGCCTCATTTTTTCTGTCTAGGGT GGATGCCTTGAGCCCTCAGCTCCAACAGTTGGCCTGTGAGTGTTATTCCCGGCTGCCCTCTTTAGGGGCTGGCTTTTCCCAAGGCCTGAA GCACACCGAGAGCTGGGAGCAGGAGCTACACAGTCTGCTGGCCTCACTGCACACCCTGCTGGGGGCCCTGTACGAGGGAGCAGAGACTGG CAGGGGTGTGGGGAAGAACGAGGAACTGCGTCTTTATCACCATCTCTTCAACAACTATGACCCAGGAAGCCGGCCAGTGCGGGAGCCTGA GGATACTGTCACCATCAGCCTCAAGGTCACCCTGACGAATCTCATCTCACTGAATGAAAAAGAGGAGACTCTCACCACTAGCGTCTGGAT TGGAATCGATTGGCAGGATTACCGACTCAACTACAGCAAGGACGACTTTGGGGGTATAGAAACCCTGCGAGTCCCTTCAGAACTCGTGTG GCTGCCAGAGATTGTGCTGGAAAACAATATTGATGGCCAGTTCGGAGTGGCCTACGACGCCAACGTGCTCGTCTACGAGGGCGGCTCCGT GACGTGGCTGCCTCCGGCCATCTACCGCAGCGTCTGCGCAGTGGAGGTCACCTACTTCCCCTTCGATTGGCAGAACTGTTCGCTTATTTT CCGCTCTCAGACGTACAATGCCGAAGAGGTGGAGTTCACTTTTGCCGTAGACAACGACGGCAAGACCATCAACAAGATCGACATCGACAC AGAGGCCTATACTGAGAACGGCGAGTGGGCCATCGACTTCTGCCCGGGGGTGATCCGCCGCCACCACGGTGGCGCCACCGACGGCCCAGG GGAGACTGACGTCATCTACTCGCTCATCATCCGCCGGAAGCCGCTCTTCTACGTCATTAACATCATCGTGCCCTGTGTGCTCATCTCGGG CCTGGTGCTGCTCGCCTACTTCCTGCCGGCGCAGGCCGGCGGCCAGAAATGCACGGTCTCCATCAACGTCCTGCTCGCCCAGACCGTCTT CTTGTTCCTCATTGCCCAGAAAATCCCAGAGACTTCTCTGAGCGTGCCGCTCCTGGGCAGGTTCCTTATTTTCGTCATGGTGGTCGCCAC GCTCATTGTCATGAATTGCGTCATCGTGCTCAACGTGTCCCAGCGGACGCCCACCACCCACGCCATGTCCCCGCGGCTGCGCCACGTTCT CCTGGAGCTGCTGCCGCGCCTCCTGGGCTCCCCGCCGCCGCCCGAGGCCCCCCGGGCCGCCTCGCCCCCAAGGCGGGCGTCGTCGGTGGG CTTATTGCTCCGCGCGGAGGAGCTGATACTGAAAAAGCCACGGAGCGAGCTCGTGTTTGAGGGGCAGAGGCACCGGCAGGGGACCTGGAC GGCTGCCTTCTGCCAGAGCCTGGGCGCCGCCGCCCCCGAGGTCCGCTGCTGTGTGGATGCCGTGAACTTCGTGGCCGAGAGCACGAGAGA TCAGGAGGCCACCGGCGAGGAAGTGTCCGACTGGGTGCGCATGGGGAATGCCCTTGACAACATCTGCTTCTGGGCCGCTCTGGTGCTCTT CAGCGTGGGCTCCAGCCTCATCTTCCTCGGGGCCTACTTCAACCGAGTGCCTGATCTCCCCTACGCGCCGTGTATCCAGCCTTAGCTCGC ACCGACTTCAATTTCCCACCCATCTCCAGTAGGAAATTGATTTTGAAAAAGTAGGCTGCCGCCACCACGGCATTATGATCCCTTCCCCCT GCTGATCAATCTGCAGTTTGTGAACTTCACAAGAATGGTGTGTGCCCGTTCCCTGGCGTGTGTAGGCCTGGCCGCAGTCCAGGGGTCAGC AGGAGGAAAGGGTTCACATAGGCTCTCAGGTGCCAGTCTTCCAGAAAGCAAGGACTGCCCTTCATTCAGCCTTGCTGACCTCCCAGCCTT TCTAAGGCTCAGCCCCACGGGACTCTGGTGGCTGCCAGCTTGTGAGCTATCTATCTATATTCATTTCATAGCCAAACAGGAGACCCCTTT GCAGGACTTGCACACAGGGAGGCTGTAGCCAGGAAACCCTCTTCTTCCCTGGTCTGGCTCTGCTGGAGCGGGTGGGAACCAAACACCTTC AGTGCTGGTGGCCCTCAGGCCCACAGGTTTAAGGCTGAGGCTGCCCTGACCCTTCCACAGTCATTTCTTCTAGGTTTTCTTGGCCCAGCA CTGCCCATCCCACCCCATGAGGCTCACTCATTGCAGATCCCAGCCCACCCTGCCCCTTTCTTCCCCACCCTGGAGGCTCTCTCTGCCTAG TCTACAGTACTGACAGAAAGCAAGGACATGCGGCCTGCATGGTGGGAGCTGGTTGAATTGTCTTTATTAACAAACAGGATATCCAAGGCC ACTACATTGAGGAGGGGTGGGGGGGGAGGGAGAAGGGTTACTTGCTGCTCACACTATATACAGATGCAAGCAAGGGGCGTGGAGAGTGAG GGCTCCCTGCTCCCTCCCTCCACCGGGGAAGGGCATGGGCTAGAAGAGGAGAGGGGGGTCGGGAATGGGGGGAATGTTTTGGCTGGCGGG >64264_64264_2_PELP1-CHRNE_PELP1_chr17_4579652_ENST00000301396_CHRNE_chr17_4806058_ENST00000293780_length(amino acids)=817AA_BP=339 MLSPRMLLPSLSPRVQPAFTQCARPQPPPHAPSPVGGRRGVFASSRHATTGTRGKMAAAVLSGPSAGSAAGVPGGTGGLSAVSSGPRLRL LLLESVSGLLQPRTGSAVAPVHPPNRSAPHLPGLMCLLRLHGSVGGAQNLSALGALVSLSNARLSSIKTRFEGLCLLSLLVGESPTELFQ QHCVSWLRSIQQVLQTQDPPATMELAVAVLRDLLRYAAQLPALFRDISMNHLPGLLTSLLGLRPECEQSALEGMKACMTYFPRACGSLKG KLASFFLSRVDALSPQLQQLACECYSRLPSLGAGFSQGLKHTESWEQELHSLLASLHTLLGALYEGAETGRGVGKNEELRLYHHLFNNYD PGSRPVREPEDTVTISLKVTLTNLISLNEKEETLTTSVWIGIDWQDYRLNYSKDDFGGIETLRVPSELVWLPEIVLENNIDGQFGVAYDA NVLVYEGGSVTWLPPAIYRSVCAVEVTYFPFDWQNCSLIFRSQTYNAEEVEFTFAVDNDGKTINKIDIDTEAYTENGEWAIDFCPGVIRR HHGGATDGPGETDVIYSLIIRRKPLFYVINIIVPCVLISGLVLLAYFLPAQAGGQKCTVSINVLLAQTVFLFLIAQKIPETSLSVPLLGR FLIFVMVVATLIVMNCVIVLNVSQRTPTTHAMSPRLRHVLLELLPRLLGSPPPPEAPRAASPPRRASSVGLLLRAEELILKKPRSELVFE GQRHRQGTWTAAFCQSLGAAAPEVRCCVDAVNFVAESTRDQEATGEEVSDWVRMGNALDNICFWAALVLFSVGSSLIFLGAYFNRVPDLP -------------------------------------------------------------- >64264_64264_3_PELP1-CHRNE_PELP1_chr17_4579652_ENST00000572293_CHRNE_chr17_4806058_ENST00000293780_length(transcript)=3465nt_BP=1067nt ATCCGCCATCACTCCGGGAACCGAGCACCCCGCTGCCTCGGCGCCCAGGCTGCTCTCTCCGCGCATGCTCCTTCCCAGCTTGAGCCCGCG AGTCCAGCCTGCCTTCACTCAGTGCGCAAGACCGCAGCCCCCTCCCCACGCCCCCTCCCCAGTAGGCGGCCGTCGCGGTGTGTTTGCGTC ATCGCGCCACGCCACCACTGGAACCCGGGGGAAGATGGCGGCAGCCGTTCTGAGTGGGCCCTCTGCGGGCTCCGCGGCTGGGGTTCCTGG CGGGACCGGGGGTCTCTCGGCAGTGAGCTCGGGCCCGCGGCTCCGCCTGCTGCTGCTGGAGAGTGTTTCTGGTTTGCTGCAACCTCGAAC GGGGTCTGCCGTTGCTCCGGTGCATCCCCCAAACCGCTCGGCCCCACATTTGCCCGGGCTCATGTGCCTATTGCGGCTGCATGGGTCGGT GGGCGGGGCCCAGAACCTTTCAGCTCTTGGGGCATTGGTGAGTCTCAGTAATGCACGTCTCAGTTCCATCAAAACTCGGTTTGAGGGCCT GTGTCTGCTGTCCCTGCTGGTAGGGGAGAGCCCCACAGAGCTATTCCAGCAGCACTGTGTGTCTTGGCTTCGGAGCATTCAGCAGGTGTT ACAGACCCAGGACCCGCCTGCCACAATGGAGCTGGCCGTGGCTGTCCTGAGGGACCTCCTCCGATATGCAGCCCAGCTGCCTGCACTGTT CCGGGACATCTCCATGAACCACCTCCCTGGCCTTCTCACCTCCCTGCTGGGCCTCAGGCCAGAGTGTGAGCAGTCAGCATTGGAAGGAAT GAAGGCTTGTATGACCTATTTCCCTCGGGCTTGTGGTTCTCTCAAAGGCAAGCTGGCCTCATTTTTTCTGTCTAGGGTGGATGCCTTGAG CCCTCAGCTCCAACAGTTGGCCTGTGAGTGTTATTCCCGGCTGCCCTCTTTAGGGGCTGGCTTTTCCCAAGGCCTGAAGCACACCGAGAG CTGGGAGCAGGAGCTACACAGTCTGCTGGCCTCACTGCACACCCTGCTGGGGGCCCTGTACGAGGGAGCAGAGACTGGCAGGGGTGTGGG GAAGAACGAGGAACTGCGTCTTTATCACCATCTCTTCAACAACTATGACCCAGGAAGCCGGCCAGTGCGGGAGCCTGAGGATACTGTCAC CATCAGCCTCAAGGTCACCCTGACGAATCTCATCTCACTGAATGAAAAAGAGGAGACTCTCACCACTAGCGTCTGGATTGGAATCGATTG GCAGGATTACCGACTCAACTACAGCAAGGACGACTTTGGGGGTATAGAAACCCTGCGAGTCCCTTCAGAACTCGTGTGGCTGCCAGAGAT TGTGCTGGAAAACAATATTGATGGCCAGTTCGGAGTGGCCTACGACGCCAACGTGCTCGTCTACGAGGGCGGCTCCGTGACGTGGCTGCC TCCGGCCATCTACCGCAGCGTCTGCGCAGTGGAGGTCACCTACTTCCCCTTCGATTGGCAGAACTGTTCGCTTATTTTCCGCTCTCAGAC GTACAATGCCGAAGAGGTGGAGTTCACTTTTGCCGTAGACAACGACGGCAAGACCATCAACAAGATCGACATCGACACAGAGGCCTATAC TGAGAACGGCGAGTGGGCCATCGACTTCTGCCCGGGGGTGATCCGCCGCCACCACGGTGGCGCCACCGACGGCCCAGGGGAGACTGACGT CATCTACTCGCTCATCATCCGCCGGAAGCCGCTCTTCTACGTCATTAACATCATCGTGCCCTGTGTGCTCATCTCGGGCCTGGTGCTGCT CGCCTACTTCCTGCCGGCGCAGGCCGGCGGCCAGAAATGCACGGTCTCCATCAACGTCCTGCTCGCCCAGACCGTCTTCTTGTTCCTCAT TGCCCAGAAAATCCCAGAGACTTCTCTGAGCGTGCCGCTCCTGGGCAGGTTCCTTATTTTCGTCATGGTGGTCGCCACGCTCATTGTCAT GAATTGCGTCATCGTGCTCAACGTGTCCCAGCGGACGCCCACCACCCACGCCATGTCCCCGCGGCTGCGCCACGTTCTCCTGGAGCTGCT GCCGCGCCTCCTGGGCTCCCCGCCGCCGCCCGAGGCCCCCCGGGCCGCCTCGCCCCCAAGGCGGGCGTCGTCGGTGGGCTTATTGCTCCG CGCGGAGGAGCTGATACTGAAAAAGCCACGGAGCGAGCTCGTGTTTGAGGGGCAGAGGCACCGGCAGGGGACCTGGACGGCTGCCTTCTG CCAGAGCCTGGGCGCCGCCGCCCCCGAGGTCCGCTGCTGTGTGGATGCCGTGAACTTCGTGGCCGAGAGCACGAGAGATCAGGAGGCCAC CGGCGAGGAAGTGTCCGACTGGGTGCGCATGGGGAATGCCCTTGACAACATCTGCTTCTGGGCCGCTCTGGTGCTCTTCAGCGTGGGCTC CAGCCTCATCTTCCTCGGGGCCTACTTCAACCGAGTGCCTGATCTCCCCTACGCGCCGTGTATCCAGCCTTAGCTCGCACCGACTTCAAT TTCCCACCCATCTCCAGTAGGAAATTGATTTTGAAAAAGTAGGCTGCCGCCACCACGGCATTATGATCCCTTCCCCCTGCTGATCAATCT GCAGTTTGTGAACTTCACAAGAATGGTGTGTGCCCGTTCCCTGGCGTGTGTAGGCCTGGCCGCAGTCCAGGGGTCAGCAGGAGGAAAGGG TTCACATAGGCTCTCAGGTGCCAGTCTTCCAGAAAGCAAGGACTGCCCTTCATTCAGCCTTGCTGACCTCCCAGCCTTTCTAAGGCTCAG CCCCACGGGACTCTGGTGGCTGCCAGCTTGTGAGCTATCTATCTATATTCATTTCATAGCCAAACAGGAGACCCCTTTGCAGGACTTGCA CACAGGGAGGCTGTAGCCAGGAAACCCTCTTCTTCCCTGGTCTGGCTCTGCTGGAGCGGGTGGGAACCAAACACCTTCAGTGCTGGTGGC CCTCAGGCCCACAGGTTTAAGGCTGAGGCTGCCCTGACCCTTCCACAGTCATTTCTTCTAGGTTTTCTTGGCCCAGCACTGCCCATCCCA CCCCATGAGGCTCACTCATTGCAGATCCCAGCCCACCCTGCCCCTTTCTTCCCCACCCTGGAGGCTCTCTCTGCCTAGTCTACAGTACTG ACAGAAAGCAAGGACATGCGGCCTGCATGGTGGGAGCTGGTTGAATTGTCTTTATTAACAAACAGGATATCCAAGGCCACTACATTGAGG AGGGGTGGGGGGGGAGGGAGAAGGGTTACTTGCTGCTCACACTATATACAGATGCAAGCAAGGGGCGTGGAGAGTGAGGGCTCCCTGCTC CCTCCCTCCACCGGGGAAGGGCATGGGCTAGAAGAGGAGAGGGGGGTCGGGAATGGGGGGAATGTTTTGGCTGGCGGGGTCCCCCCTCCA >64264_64264_3_PELP1-CHRNE_PELP1_chr17_4579652_ENST00000572293_CHRNE_chr17_4806058_ENST00000293780_length(amino acids)=817AA_BP=339 MLSPRMLLPSLSPRVQPAFTQCARPQPPPHAPSPVGGRRGVFASSRHATTGTRGKMAAAVLSGPSAGSAAGVPGGTGGLSAVSSGPRLRL LLLESVSGLLQPRTGSAVAPVHPPNRSAPHLPGLMCLLRLHGSVGGAQNLSALGALVSLSNARLSSIKTRFEGLCLLSLLVGESPTELFQ QHCVSWLRSIQQVLQTQDPPATMELAVAVLRDLLRYAAQLPALFRDISMNHLPGLLTSLLGLRPECEQSALEGMKACMTYFPRACGSLKG KLASFFLSRVDALSPQLQQLACECYSRLPSLGAGFSQGLKHTESWEQELHSLLASLHTLLGALYEGAETGRGVGKNEELRLYHHLFNNYD PGSRPVREPEDTVTISLKVTLTNLISLNEKEETLTTSVWIGIDWQDYRLNYSKDDFGGIETLRVPSELVWLPEIVLENNIDGQFGVAYDA NVLVYEGGSVTWLPPAIYRSVCAVEVTYFPFDWQNCSLIFRSQTYNAEEVEFTFAVDNDGKTINKIDIDTEAYTENGEWAIDFCPGVIRR HHGGATDGPGETDVIYSLIIRRKPLFYVINIIVPCVLISGLVLLAYFLPAQAGGQKCTVSINVLLAQTVFLFLIAQKIPETSLSVPLLGR FLIFVMVVATLIVMNCVIVLNVSQRTPTTHAMSPRLRHVLLELLPRLLGSPPPPEAPRAASPPRRASSVGLLLRAEELILKKPRSELVFE GQRHRQGTWTAAFCQSLGAAAPEVRCCVDAVNFVAESTRDQEATGEEVSDWVRMGNALDNICFWAALVLFSVGSSLIFLGAYFNRVPDLP -------------------------------------------------------------- >64264_64264_4_PELP1-CHRNE_PELP1_chr17_4579652_ENST00000574876_CHRNE_chr17_4806058_ENST00000293780_length(transcript)=3269nt_BP=871nt ACTGGAACCCGGGGGAAGATGGCGGCAGCCGTTCTGAGTGGGCCCTCTGCGGGCTCCGCGGCTGGGGTTCCTGGCGGGACCGGGGGTCTC TCGGCAGTGAGCTCGGGCCCGCGGCTCCGCCTGCTGCTGCTGGAGAGTGTTTCTGGTTTGCTGCAACCTCGAACGGGGTCTGCCGTTGCT CCGGTGCATCCCCCAAACCGCTCGGCCCCACATTTGCCCGGGCTCATGTGCCTATTGCGGCTGCATGGGTCGGTGGGCGGGGCCCAGAAC CTTTCAGCTCTTGGGGCATTGGTGAGTCTCAGTAATGCACGTCTCAGTTCCATCAAAACTCGGTTTGAGGGCCTGTGTCTGCTGTCCCTG CTGGTAGGGGAGAGCCCCACAGAGCTATTCCAGCAGCACTGTGTGTCTTGGCTTCGGAGCATTCAGCAGGTGTTACAGACCCAGGACCCG CCTGCCACAATGGAGCTGGCCGTGGCTGTCCTGAGGGACCTCCTCCGATATGCAGCCCAGCTGCCTGCACTGTTCCGGGACATCTCCATG AACCACCTCCCTGGCCTTCTCACCTCCCTGCTGGGCCTCAGGCCAGAGTGTGAGCAGTCAGCATTGGAAGGAATGAAGGCTTGTATGACC TATTTCCCTCGGGCTTGTGGTTCTCTCAAAGGCAAGCTGGCCTCATTTTTTCTGTCTAGGGTGGATGCCTTGAGCCCTCAGCTCCAACAG TTGGCCTGTGAGTGTTATTCCCGGCTGCCCTCTTTAGGGGCTGGCTTTTCCCAAGGCCTGAAGCACACCGAGAGCTGGGAGCAGGAGCTA CACAGTCTGCTGGCCTCACTGCACACCCTGCTGGGGGCCCTGTACGAGGGAGCAGAGACTGGCAGGGGTGTGGGGAAGAACGAGGAACTG CGTCTTTATCACCATCTCTTCAACAACTATGACCCAGGAAGCCGGCCAGTGCGGGAGCCTGAGGATACTGTCACCATCAGCCTCAAGGTC ACCCTGACGAATCTCATCTCACTGAATGAAAAAGAGGAGACTCTCACCACTAGCGTCTGGATTGGAATCGATTGGCAGGATTACCGACTC AACTACAGCAAGGACGACTTTGGGGGTATAGAAACCCTGCGAGTCCCTTCAGAACTCGTGTGGCTGCCAGAGATTGTGCTGGAAAACAAT ATTGATGGCCAGTTCGGAGTGGCCTACGACGCCAACGTGCTCGTCTACGAGGGCGGCTCCGTGACGTGGCTGCCTCCGGCCATCTACCGC AGCGTCTGCGCAGTGGAGGTCACCTACTTCCCCTTCGATTGGCAGAACTGTTCGCTTATTTTCCGCTCTCAGACGTACAATGCCGAAGAG GTGGAGTTCACTTTTGCCGTAGACAACGACGGCAAGACCATCAACAAGATCGACATCGACACAGAGGCCTATACTGAGAACGGCGAGTGG GCCATCGACTTCTGCCCGGGGGTGATCCGCCGCCACCACGGTGGCGCCACCGACGGCCCAGGGGAGACTGACGTCATCTACTCGCTCATC ATCCGCCGGAAGCCGCTCTTCTACGTCATTAACATCATCGTGCCCTGTGTGCTCATCTCGGGCCTGGTGCTGCTCGCCTACTTCCTGCCG GCGCAGGCCGGCGGCCAGAAATGCACGGTCTCCATCAACGTCCTGCTCGCCCAGACCGTCTTCTTGTTCCTCATTGCCCAGAAAATCCCA GAGACTTCTCTGAGCGTGCCGCTCCTGGGCAGGTTCCTTATTTTCGTCATGGTGGTCGCCACGCTCATTGTCATGAATTGCGTCATCGTG CTCAACGTGTCCCAGCGGACGCCCACCACCCACGCCATGTCCCCGCGGCTGCGCCACGTTCTCCTGGAGCTGCTGCCGCGCCTCCTGGGC TCCCCGCCGCCGCCCGAGGCCCCCCGGGCCGCCTCGCCCCCAAGGCGGGCGTCGTCGGTGGGCTTATTGCTCCGCGCGGAGGAGCTGATA CTGAAAAAGCCACGGAGCGAGCTCGTGTTTGAGGGGCAGAGGCACCGGCAGGGGACCTGGACGGCTGCCTTCTGCCAGAGCCTGGGCGCC GCCGCCCCCGAGGTCCGCTGCTGTGTGGATGCCGTGAACTTCGTGGCCGAGAGCACGAGAGATCAGGAGGCCACCGGCGAGGAAGTGTCC GACTGGGTGCGCATGGGGAATGCCCTTGACAACATCTGCTTCTGGGCCGCTCTGGTGCTCTTCAGCGTGGGCTCCAGCCTCATCTTCCTC GGGGCCTACTTCAACCGAGTGCCTGATCTCCCCTACGCGCCGTGTATCCAGCCTTAGCTCGCACCGACTTCAATTTCCCACCCATCTCCA GTAGGAAATTGATTTTGAAAAAGTAGGCTGCCGCCACCACGGCATTATGATCCCTTCCCCCTGCTGATCAATCTGCAGTTTGTGAACTTC ACAAGAATGGTGTGTGCCCGTTCCCTGGCGTGTGTAGGCCTGGCCGCAGTCCAGGGGTCAGCAGGAGGAAAGGGTTCACATAGGCTCTCA GGTGCCAGTCTTCCAGAAAGCAAGGACTGCCCTTCATTCAGCCTTGCTGACCTCCCAGCCTTTCTAAGGCTCAGCCCCACGGGACTCTGG TGGCTGCCAGCTTGTGAGCTATCTATCTATATTCATTTCATAGCCAAACAGGAGACCCCTTTGCAGGACTTGCACACAGGGAGGCTGTAG CCAGGAAACCCTCTTCTTCCCTGGTCTGGCTCTGCTGGAGCGGGTGGGAACCAAACACCTTCAGTGCTGGTGGCCCTCAGGCCCACAGGT TTAAGGCTGAGGCTGCCCTGACCCTTCCACAGTCATTTCTTCTAGGTTTTCTTGGCCCAGCACTGCCCATCCCACCCCATGAGGCTCACT CATTGCAGATCCCAGCCCACCCTGCCCCTTTCTTCCCCACCCTGGAGGCTCTCTCTGCCTAGTCTACAGTACTGACAGAAAGCAAGGACA TGCGGCCTGCATGGTGGGAGCTGGTTGAATTGTCTTTATTAACAAACAGGATATCCAAGGCCACTACATTGAGGAGGGGTGGGGGGGGAG GGAGAAGGGTTACTTGCTGCTCACACTATATACAGATGCAAGCAAGGGGCGTGGAGAGTGAGGGCTCCCTGCTCCCTCCCTCCACCGGGG AAGGGCATGGGCTAGAAGAGGAGAGGGGGGTCGGGAATGGGGGGAATGTTTTGGCTGGCGGGGTCCCCCCTCCATTCCCTGGAGTTTGGG >64264_64264_4_PELP1-CHRNE_PELP1_chr17_4579652_ENST00000574876_CHRNE_chr17_4806058_ENST00000293780_length(amino acids)=762AA_BP=284 MAAAVLSGPSAGSAAGVPGGTGGLSAVSSGPRLRLLLLESVSGLLQPRTGSAVAPVHPPNRSAPHLPGLMCLLRLHGSVGGAQNLSALGA LVSLSNARLSSIKTRFEGLCLLSLLVGESPTELFQQHCVSWLRSIQQVLQTQDPPATMELAVAVLRDLLRYAAQLPALFRDISMNHLPGL LTSLLGLRPECEQSALEGMKACMTYFPRACGSLKGKLASFFLSRVDALSPQLQQLACECYSRLPSLGAGFSQGLKHTESWEQELHSLLAS LHTLLGALYEGAETGRGVGKNEELRLYHHLFNNYDPGSRPVREPEDTVTISLKVTLTNLISLNEKEETLTTSVWIGIDWQDYRLNYSKDD FGGIETLRVPSELVWLPEIVLENNIDGQFGVAYDANVLVYEGGSVTWLPPAIYRSVCAVEVTYFPFDWQNCSLIFRSQTYNAEEVEFTFA VDNDGKTINKIDIDTEAYTENGEWAIDFCPGVIRRHHGGATDGPGETDVIYSLIIRRKPLFYVINIIVPCVLISGLVLLAYFLPAQAGGQ KCTVSINVLLAQTVFLFLIAQKIPETSLSVPLLGRFLIFVMVVATLIVMNCVIVLNVSQRTPTTHAMSPRLRHVLLELLPRLLGSPPPPE APRAASPPRRASSVGLLLRAEELILKKPRSELVFEGQRHRQGTWTAAFCQSLGAAAPEVRCCVDAVNFVAESTRDQEATGEEVSDWVRMG -------------------------------------------------------------- |
Top |
Fusion Gene PPI Analysis for PELP1-CHRNE |
Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in |
Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
- Retained PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
- Lost PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
- Retained PPIs, but lost function due to frame-shift fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs for PELP1-CHRNE |
Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.8 2021-05-08) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
Related Diseases for PELP1-CHRNE |
Diseases associated with fusion partners. (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |